Catalyst Wire Dossier Catalyst Wire Dossier

Long-acting injectable HIV therapy

cabotegravir + rilpivirine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Long-acting injectable HIV therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs [Phase 2]

See pricing